Moneycontrol PRO
Live Now |Super25 3.0- India’s Largest Online Stock Traders Conference brought to you by Moneycontrol Pro & Espresso
you are here: HomeNewsTrendsHealth

India logs 14,313 new COVID-19 cases, 549 deaths; active cases at 1,61,555

The death toll climbed to 4,57,740 with 549 more fatalities, according to the data updated at 8 am.

October 30, 2021 / 10:41 AM IST
Representative image

Representative image

With 14,313 people testing positive for coronavirus in a day, India’s total tally of COVID-19 cases rose to 3,42,60,470, while the active cases were recorded at 1,61,555, according to the Union health ministry data updated on Saturday.

The death toll climbed to 4,57,740 with 549 more fatalities, according to the data updated at 8 am.

The daily rise in new coronavirus infections has been below 30,000 for 36 straight days and less than 50,000 daily new cases have been reported for 125 consecutive days now.

The active cases comprise 0.47 per cent of the total infections, the lowest since March 2020, while the national COVID-19 recovery rate was recorded at 98.19 per cent, the ministry said.

An increase of 221 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The number of people who have recuperated from the disease surged to 3,36,41,175, while the case fatality rate has increased to 1.34 per cent.

The daily positivity rate was recorded at 1.22 per cent.

It has been less than 2 per cent for the last 26 days.

The weekly positivity rate was recorded at 1.18 per cent.

It has been below 2 per cent for the last 36 days, according to the health ministry.

The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 105.43 crore.

India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.

It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.

India crossed the grim milestone of two crore on May 4 and three crore on June 23.

Follow our full coverage of the coronavirus pandemic here.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

PTI
first published: Oct 30, 2021 10:41 am
Sections
ISO 27001 - BSI Assurance Mark